IGF2BP3 and astrocytoma (excluding glioblastoma): For PFI, the higher expression of IGF2BP3 had a worse PFI in a subgroup of WHO grade: G3, a subgroup of IDH status: WT, a subgroup of IDH status: Mut, a subgroup of 1p/19q codeletion: non−codel, a subgroup of Primary therapy outcome: PD, a subgroup of Gender: Female, a subgroup of Gender: Male, a subgroup of Race: Black or African American, a subgroup of Race: White, a subgroup of Age: <=60, a subgroup of Age: >60, and a subgroup of Histological type: Astrocytoma (Supplementary Figures 6A–L).